Merck Remains on Course in a Challenging Environment

Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science

06-Aug-2020 - Merck registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly. In comparison with the year-earlier quarter, Group sales increased by 3.7% to € 4.1 billion. EBITDA pre, the Group’s most ...

Bayer: Solid performance despite COVID-19 impact

Ensuring employee safety and maintaining supply chains remain top priorities

05-Aug-2020 - The Bayer Group’s businesses turned in a solid performance in the second quarter of 2020 despite the COVID-19 pandemic and the associated uncertainties. “Thanks to the growth in our agricultural business, we raised EBITDA before special items – and we did so in a challenging environment,” said ...

Bayer: Good start to 2020

Activities marked by COVID-19

27-Apr-2020 - The Bayer Group has registered a good start to 2020, with business activities in the first quarter greatly marked by the COVID-19 pandemic. “With our life science product portfolio in the areas of health and nutrition, we have shown our ability to successfully continue our business operations in ...

Sartorius off to a dynamic start in fiscal 2020

Coronavirus pandemic so far with an overall neutral impact, but substantially different effects on the divisions

22-Apr-2020 - Sartorius started off fiscal 2020 dynamically with significant double-digit growth in order intake, sales revenue and earnings. “We are very satisfied overall with our first-quarter results and confident about our business progress in the further course of the year,” commented CEO Dr. Joachim ...

Merck Generates Profitable Growth in Q3 2019

15-Nov-2019 - Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...

Bayer: Encouraging business performance across all divisions

Agreements signed to divest Currenta and Animal Health

30-Oct-2019 - Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales ...

Sartorius continues on its dynamic growth track

21-Oct-2019 - Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the year as ...

Merck Sees Profit Jump in Q2

Net sales growth thanks to organic performance

09-Aug-2019 - Merck generated strong net sales growth in the second quarter of 2019, primarily on an organic basis. EBITDA pre grew very strongly and was also driven by organic performance. Merck confirmed its full-year forecast for 2019. “We achieved sales growth in all business sectors and regions. The jump ...

Merck Confirms Forecast for Organic Performance in 2019

Business in Asia drives Group organic growth

14-May-2019 - Merck significantly increased net sales in the first quarter of 2019, primarily on an organic basis. By contrast, EBITDA pre saw a slight organic decline and was adversely impacted by the absence of positive one-time effects from the previous year. Merck confirmed its full-year forecast for ...

Bayer: strong operational start to the year

25-Apr-2019 - The Bayer Group achieved a strong start to the year in its operational business. “A major factor in this success was our agriculture business, while Pharmaceuticals also delivered encouraging performance,” said Werner Baumann, Chairman of the Board of Management, on Thursday when presenting the ...